[Pharmacokinetics of cicletanine hydrochloride in patients with renal insufficiency]. 1987

J M Lize, and J L Durand, and P Jungers, and C Divine, and M Bohbot, and G Fredj, and A Thuillier

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J M Lize, and J L Durand, and P Jungers, and C Divine, and M Bohbot, and G Fredj, and A Thuillier
January 1988, Drugs under experimental and clinical research,
J M Lize, and J L Durand, and P Jungers, and C Divine, and M Bohbot, and G Fredj, and A Thuillier
January 1988, Drugs under experimental and clinical research,
J M Lize, and J L Durand, and P Jungers, and C Divine, and M Bohbot, and G Fredj, and A Thuillier
September 1984, Antimicrobial agents and chemotherapy,
J M Lize, and J L Durand, and P Jungers, and C Divine, and M Bohbot, and G Fredj, and A Thuillier
January 1986, Antimicrobial agents and chemotherapy,
J M Lize, and J L Durand, and P Jungers, and C Divine, and M Bohbot, and G Fredj, and A Thuillier
April 1990, Journal of clinical pharmacology,
J M Lize, and J L Durand, and P Jungers, and C Divine, and M Bohbot, and G Fredj, and A Thuillier
January 1999, British journal of clinical pharmacology,
J M Lize, and J L Durand, and P Jungers, and C Divine, and M Bohbot, and G Fredj, and A Thuillier
February 1984, Antimicrobial agents and chemotherapy,
J M Lize, and J L Durand, and P Jungers, and C Divine, and M Bohbot, and G Fredj, and A Thuillier
March 1981, Antimicrobial agents and chemotherapy,
J M Lize, and J L Durand, and P Jungers, and C Divine, and M Bohbot, and G Fredj, and A Thuillier
April 1987, Antimicrobial agents and chemotherapy,
J M Lize, and J L Durand, and P Jungers, and C Divine, and M Bohbot, and G Fredj, and A Thuillier
October 1995, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
Copied contents to your clipboard!